Feng Niu

Title: The Innovations of Feng Niu in Tumor Detection

Introduction

Feng Niu is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of molecular diagnostics, particularly in the detection of tumors. His innovative work focuses on utilizing excrement as a sample for detecting colorectal cancer, which has the potential to revolutionize cancer screening methods.

Latest Patents

Feng Niu holds a patent for a molecular detection/diagnosis reagent for tumors. This invention discloses a tumor molecular detection/diagnostic reagent that includes an SDC2 gene methylation detection reagent. The methylation level of the SDC2 gene detected in excrement shows an extremely high relevance to the onset of colorectal cancer. The sensitivity of the SDC2 gene in excrement is 87 percent, while the specificity is up to 98 percent or even higher than that in tissue. This advancement could lead to earlier and more accurate diagnoses of colorectal cancer.

Career Highlights

Throughout his career, Feng Niu has worked with notable companies, including Creative Biosciences (Guangzhou) Co., Ltd. and Creative Biosciences Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in molecular diagnostics.

Collaborations

Feng Niu has collaborated with several professionals in his field, including Hongzhi Zou and Shan Wu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Feng Niu's work in tumor detection represents a significant step forward in cancer diagnostics. His innovative approach to using excrement for molecular detection has the potential to improve early detection rates for colorectal cancer, ultimately saving lives.